Picture of Celltrion logo

068270 Celltrion Cashflow Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Annual cashflow statement for Celltrion, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARS/AAnnual Audited AccountsARS/AAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line301,443519,232595,779542,566539,707
Depreciation
Amortisation
Non-Cash Items105,646222,995237,554197,087127,332
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-86,814-570,790-136,334-965,179-375,561
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities473,994350,747911,159864537,159
Capital Expenditures-286,138-541,392-321,565-311,986-353,732
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items34,69769,409-34,26014,934214,867
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities-251,441-471,983-355,825-297,051-138,865
Financing Cash Flow Items-44,191265,09383,36180,562667,724
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-85,920265,988-69,278-350,219-385,115
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash135,590138,156504,032-637,13913,425